Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in September 2012 on request of the sponsor.
On 9 July 2003, orphan designation (EU/3/03/155) was granted by the European Commission to Cell Control Biomedical Laboratories AG, Germany, for murine anti-idiotypic antibody against OC125 antibody against CA125 antigen (ACA125) for the treatment of ovarian cancer.
The sponsorship was transferred to Menarini Ricerche S.p.A. in December 2004.
For a list of the administrative updates to this public summary of opinion please refer to the PDF document below.
Murine anti-idiotypic antibody against OC125 antibody against CA125 antigen
|Disease / condition||
Treatment of ovarian cancer
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.